Filter

USCAP 2025 Contemporary Issues in Breast Pathology

Name: USCAP 2025 Contemporary Issues in Breast Pathology
Availability: InStock

$56

Secure CheckoutEncrypted payments—shop with confidence

Google Drive AccessPrivate link to your digital course files

High-Yield Study ContentConcise CME & Board Review resources

Responsive Email SupportHelpful answers for orders & downloads

Categories: Obstetrics and Gynecology, Oncology-Hematology, Pathology, Uncategorized, USCAP CME

Description

USCAP 2025 Contemporary Issues in Breast Pathology

Original release date: July 28, 2025

Course Description
This course will provide a comprehensive review and update of the pathologic diagnosis and clinical significance of benign, in situ and malignant lesions of the breast identified in surgical specimens and core needle biopsies. The most current adjunctive immunohistochemical and molecular studies to assist in the diagnosis and classification of benign and malignant breast lesions and to guide patient management will be emphasized.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

Describe the diagnostic criteria and clinical significance of a variety of benign, in situ and malignant breast lesions encountered in surgical specimens and core needle biopsies
Discuss differential diagnostic problems in breast pathology and the uses and limitations of ancillary immunohistochemical and molecular tests in arriving at the correct diagnosis
Discuss prognostic and predictive assays in patients with breast cancer

Intraductal Proliferative Lesions – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document

Update on Classification and Management of LCIS – Stuart Schnitt, MD

Section: 1 Presentation 1 Document

Contemporary Issues in Breast Core Needle Biopsies – Laura Collins, MD

Section: 1 Presentation 1 Document

Digital Slides: Small Glandular Proliferations – Laura Collins, MD

Section: 1 Presentation 1 Document

Digital Slides: Atypical Intraductal Proliferations – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Inflammatory and Reactive Lesions – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Papillary Proliferations – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document

Challenging Fibroepithelial Lesions – Puay Hoon Tan, MD

Section: 1 Presentation 1 Document

Apocrine Proliferations – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Digital Slides: Fibroepithelial lesions – Puay Hoon Tan, MD

Section: 1 Presentation 2 Documents

Spindle Cell Lesions – Cecily Quinn, MD, FRCPath

Section: 1 Presentation 1 Document

Vascular Lesions – Gregory Bean, MD, PhD

Section: 1 Presentation 1 Document
Applications of Molecular Testing in Breast Cancer – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document 1 Certificate 1 Survey
Classic Triple Negative Breast Cancers, TILS and the Immune Microenvironment – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document
Special Type Triple Negative Breast Cancers – Laura Collins, MD

Section: 1 Presentation 1 Document
HER2 Low and ER Low Breast Cancers – Stuart Schnitt, MD

Section: 1 Presentation 1 Document
Pathologic Evaluation of Specimens After Neoadjuvant Therapy – Gregory Bean, MD, PhD

Section: 1 Presentation 1 Document
Digital Slides: Spindle Cell and Vascular Lesions – Gregory Bean, MD, PhD

Section: 1 Presentation 2 Documents
Digital Slides: Triple Negative Breast Neoplasms – Stuart Schnitt, MD

Section: 1 Presentation 1 Document
Mucinous and Neuroendocrine Lesions – Puay Hoon Tan, MD

Section: 1 Presentation 1 Document
Specimen Handling and Margin Evaluation – Laura Collins, MD

Section: 1 Presentation 1 Document
Epithelial-Myoepithelial Proliferations – Puay Hoon Tan, MD

Section: 1 Presentation 1 Document
Uncommon Clinical Scenarios – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document
Digital Slides: Mucinous Lesions and ER+ Breast Cancers – Ashley Cimino-Mathews, MD

Section: 1 Presentation 1 Document
Digital Slides: Unusual Breast Lesions – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document
Uncommon Types of Invasive Breast Cancers – Gregory Bean, MD, PhD

Section: 1 Presentation 1 Document
Contemporary Lymph Node Evaluation – Edi Brogi, MD, PhD

Section: 1 Presentation 1 Document
Applications of AI to Breast Pathology – Stuart Schnitt, MD

Section: 1 Presentation 1 Document
FREE SECTION: Panel Discussion and Q&A

Section: 8 Presentations

Tags: AI in breast pathology, ancillary testing breast pathology, ancillary tests breast pathology, apocrine proliferations breast, atypical ductal hyperplasia, atypical intraductal proliferations, benign breast lesions, benign breast lesions diagnosis, breast cancer immune microenvironment, breast cancer molecular markers, breast cancer pathology, breast core biopsy interpretation, breast core needle biopsy interpretation, breast lesion classification, breast lymph node evaluation, breast neoplasms, breast pathology academic course, breast pathology best practices, breast pathology classification, breast pathology clinical significance, breast pathology CME, breast pathology community pathologists, breast pathology continuing education, breast pathology diagnosis, breast pathology differential diagnosis, breast pathology digital slides, breast pathology education, breast pathology for fellows, breast pathology for pathologists, breast pathology for residents, breast pathology for trainees, breast pathology immunohistochemistry, breast pathology management, breast pathology margin assessment, breast pathology molecular diagnostics, breast pathology molecular studies, breast pathology online course, breast pathology panel discussion, breast pathology Q&A, breast pathology review, breast pathology specimen handling, breast pathology training, breast pathology update, breast specimen handling, breast surgical pathology, contemporary breast pathology, core needle biopsy breast, digital pathology breast, ductal carcinoma in situ, ductal proliferative lesions, epithelial-myoepithelial proliferations, ER low breast cancer, fibroepithelial lesions breast, HER2 low breast cancer, immune microenvironment breast cancer, immunohistochemistry breast lesions, inflammatory breast lesions, intraductal proliferative lesions, LCIS management, lymph node evaluation breast cancer, malignant breast lesions, malignant breast lesions pathology, margin evaluation breast specimens, molecular testing breast cancer, mucinous breast lesions, mucinous lesions breast, neoadjuvant therapy breast, neoadjuvant therapy breast cancer, neuroendocrine breast lesions, neuroendocrine lesions breast, papillary breast lesions, papillary proliferations breast, pathologic evaluation breast specimens, predictive assays breast cancer, prognostic assays breast cancer, reactive breast lesions, small glandular proliferations, spindle cell lesions breast, TILS breast cancer, triple negative breast cancer, triple negative breast cancer pathology, uncommon breast cancers, uncommon invasive breast cancers, unusual breast lesions, USCAP 2025 Contemporary Issues in Breast Pathology, USCAP breast cancer course, USCAP breast course, USCAP breast pathology 2025, USCAP breast pathology course, USCAP CME, USCAP pathology education, USCAP pathology update, vascular lesions breast

USCAP 2025 Contemporary Issues in Breast Pathology

USCAP 2025 Contemporary Issues in Breast Pathology

Intraductal Proliferative Lesions – Ashley Cimino-Mathews, MD

Update on Classification and Management of LCIS – Stuart Schnitt, MD

Contemporary Issues in Breast Core Needle Biopsies – Laura Collins, MD

Digital Slides: Small Glandular Proliferations – Laura Collins, MD

Digital Slides: Atypical Intraductal Proliferations – Cecily Quinn, MD, FRCPath

Inflammatory and Reactive Lesions – Cecily Quinn, MD, FRCPath

Papillary Proliferations – Edi Brogi, MD, PhD

Challenging Fibroepithelial Lesions – Puay Hoon Tan, MD

Apocrine Proliferations – Cecily Quinn, MD, FRCPath

Digital Slides: Fibroepithelial lesions – Puay Hoon Tan, MD

Spindle Cell Lesions – Cecily Quinn, MD, FRCPath

Vascular Lesions – Gregory Bean, MD, PhD

Applications of Molecular Testing in Breast Cancer – Ashley Cimino-Mathews, MD

Classic Triple Negative Breast Cancers, TILS and the Immune Microenvironment – Ashley Cimino-Mathews, MD

Special Type Triple Negative Breast Cancers – Laura Collins, MD

HER2 Low and ER Low Breast Cancers – Stuart Schnitt, MD

Pathologic Evaluation of Specimens After Neoadjuvant Therapy – Gregory Bean, MD, PhD

Digital Slides: Spindle Cell and Vascular Lesions – Gregory Bean, MD, PhD

Digital Slides: Triple Negative Breast Neoplasms – Stuart Schnitt, MD

Mucinous and Neuroendocrine Lesions – Puay Hoon Tan, MD

Specimen Handling and Margin Evaluation – Laura Collins, MD

Epithelial-Myoepithelial Proliferations – Puay Hoon Tan, MD

Uncommon Clinical Scenarios – Edi Brogi, MD, PhD

Digital Slides: Mucinous Lesions and ER+ Breast Cancers – Ashley Cimino-Mathews, MD

Digital Slides: Unusual Breast Lesions – Edi Brogi, MD, PhD

Uncommon Types of Invasive Breast Cancers – Gregory Bean, MD, PhD

Contemporary Lymph Node Evaluation – Edi Brogi, MD, PhD

Applications of AI to Breast Pathology – Stuart Schnitt, MD

FREE SECTION: Panel Discussion and Q&A

Related products

Login

Register